Scadden David
SEC Form 4 insider trading activity
Scadden David has filed 5 SEC Form 4 filings (33 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Jun 23, 2026.
On the most recent filing, Scadden David is listed as Director at AGIOS PHARMACEUTICALS, INC. Inside the rolling window, Scadden David reported no open-market purchases and 1 open-market sale totaling $9K in AGIO.
Companies traded
Other insiders at AGIO
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$9K
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
Frequently asked questions
How many SEC Form 4 filings has Scadden David made?
Scadden David has filed 5 SEC Form 4 filings (33 transaction rows) across 1 company since 2025.
Which companies does Scadden David trade?
Scadden David has filed SEC Form 4 disclosures for 1 company, including AGIO.
When was Scadden David's most recent SEC Form 4 filing?
Scadden David's most recent SEC Form 4 filing on Tracefour is dated Jun 23, 2026.
What is Scadden David's total buy and sell value in the current window?
Inside the rolling retention window, Scadden David bought $0 and sold $9K based on SEC Form 4 filings.
What was Scadden David's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 200 AGIO shares on 2025-11-12, worth $9K, per SEC Form 4 filings.